Aaron L. Sarver

7.4k total citations · 1 hit paper
76 papers, 4.5k citations indexed

About

Aaron L. Sarver is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Aaron L. Sarver has authored 76 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 26 papers in Cancer Research and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Aaron L. Sarver's work include MicroRNA in disease regulation (18 papers), Cancer-related molecular mechanisms research (12 papers) and Sarcoma Diagnosis and Treatment (10 papers). Aaron L. Sarver is often cited by papers focused on MicroRNA in disease regulation (18 papers), Cancer-related molecular mechanisms research (12 papers) and Sarcoma Diagnosis and Treatment (10 papers). Aaron L. Sarver collaborates with scholars based in United States, Sweden and Netherlands. Aaron L. Sarver's co-authors include Subbaya Subramanian, Lihua Li, Mark W. Murphy, Vivian J. Bardwell, David Zarkower, Clifford J. Steer, Michael D. Griswold, Jaime F. Modiano, Venugopal Thayanithy and David A. Largaespada and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Aaron L. Sarver

76 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

DMRT1 prevents female reprogramming in the postnatal mammalian testis

2011 458 citations Aaron L. Sarver et al. profile →

Peers

Countries citing papers authored by Aaron L. Sarver

Since Specialization

Citations

This map shows the geographic impact of Aaron L. Sarver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron L. Sarver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron L. Sarver more than expected).

Fields of papers citing papers by Aaron L. Sarver

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aaron L. Sarver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron L. Sarver. The network helps show where Aaron L. Sarver may publish in the future.

Co-authorship network of co-authors of Aaron L. Sarver

This figure shows the co-authorship network connecting the top 25 collaborators of Aaron L. Sarver. A scholar is included among the top collaborators of Aaron L. Sarver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aaron L. Sarver. Aaron L. Sarver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Genomically Complex Human Angiosarcoma and Canine Hemangiosarcoma Establish Convergent Angiogenic Transcriptional Programs Driven by Novel Gene Fusions 2021 ·Molecular Cancer Research ·Jong Hyuk Kim, Kate Megquier, Rachael Thomas, Aaron L. Sarver, Jung Min Song, (unknown), (unknown), (unknown), Michael A. Linden, Paari Murugan, (unknown), Colleen L. Forster, Ingegerd Elvers, Ross Swofford, Jason Turner-Maier, Elinor K. Karlsson, Matthew Breen, Kerstin Lindblad‐Toh, Jaime F. Modiano	16
2	Nearly Half of TP53 Germline Variants Predicted To Be Pathogenic in Patients With Osteosarcoma Are De Novo: A Report From the Children’s Oncology Group 2020 ·JCO Precision Oncology ·(unknown), Nathan Pankratz, Anthony J. Hooten, (unknown), Aaron L. Sarver, Lauren J. Mills, David Malkin, (unknown), Logan G. Spector	12
3	Comparative analysis of genome-wide DNA methylation identifies patterns that associate with conserved transcriptional programs in osteosarcoma 2020 ·Bone ·Lauren J. Mills, Milcah C. Scott, Pankti Shah, (unknown), (unknown), Benjamin Auch, (unknown), Kenneth B. Beckman, Logan G. Spector, Aaron L. Sarver, Subbaya Subramanian, Todd Richmond, Jaime F. Modiano	9
4	Treatment Combining CD200 Immune Checkpoint Inhibitor and Tumor-Lysate Vaccination after Surgery for Pet Dogs with High-Grade Glioma 2019 ·Cancers ·Michael R. Olin, (unknown), Christopher A. Pennell, Aaron L. Sarver, Clark C. Chen, Christopher L. Moertel, Matthew A. Hunt, G. Elizabeth Pluhar	31
5	OMCD: OncomiR Cancer Database 2018 ·BMC Cancer ·Aaron L. Sarver, Anne E. Sarver, Ce Yuan, Subbaya Subramanian	44
6	Comparative Transcriptome Analysis Quantifies Immune Cell Transcript Levels, Metastatic Progression, and Survival in Osteosarcoma 2017 ·Cancer Research ·Milcah C. Scott, Nuri A. Temiz, Anne E. Sarver, Rebecca S. LaRue, Susan K. Rathe, Jyotika Varshney, Natalie K. Wolf, Branden S. Moriarity, Timothy D. O’Brien, Logan G. Spector, David A. Largaespada, Jaime F. Modiano, Subbaya Subramanian, Aaron L. Sarver	84
7	Safe and Effective Sarcoma Therapy through Bispecific Targeting of EGFR and uPAR 2017 ·Molecular Cancer Therapeutics ·Antonella Borgatti, Joseph S. Koopmeiners, Aaron L. Sarver, (unknown), (unknown), D.A. Todhunter, Anthony E. Rizzardi, Jonathan C. Henriksen, Stephen C. Schmechel, Colleen L. Forster, Jong Hyuk Kim, Jerry Froelich, (unknown), Michael S. Henson, Matthew Breen, Kerstin Lindblad‐Toh, (unknown), (unknown), Jaime F. Modiano, Daniel A. Vallera	33
8	Sleeping Beauty Insertional Mutagenesis in Mice Identifies Drivers of Steatosis-Associated Hepatic Tumors 2017 ·Cancer Research ·Barbara R. Tschida, Nuri A. Temiz, (unknown), (unknown), Jesse D. Riordan, (unknown), (unknown), Sandra Wagner, Wendy A. Hudson, Michael A. Linden, Khalid Amin, (unknown), (unknown), Aaron L. Sarver, Ju Dong Yang, Lewis R. Roberts, Joseph H. Nadeau, Adam J. Dupuy, Vincent W. Keng, David A. Largaespada	34
9	Transposon Mutagenesis Screen Identifies Potential Lung Cancer Drivers and CUL3 as a Tumor Suppressor 2015 ·Molecular Cancer Research ·Casey R. Dorr, (unknown), Madison T. Weg, (unknown), (unknown), (unknown), (unknown), (unknown), Sean R. Landman, Maeve O’Sullivan, Michael Steinbach, Aaron L. Sarver, Kevin A.T. Silverstein, David A. Largaespada, Timothy K. Starr	34
10	Identification, by systematic RNA sequencing, of novel candidate biomarkers and therapeutic targets in human soft tissue tumors 2015 ·Laboratory Investigation ·Anne E. Sarver, Aaron L. Sarver, Venugopal Thayanithy, Subbaya Subramanian	13
11	Lats2 is critical for the pluripotency and proper differentiation of stem cells 2014 ·Cell Death and Differentiation ·Yael Aylon, Aaron L. Sarver, Ayala Tovy, Elena Ainbinder, Moshe Oren	22
12	Profiling Bortezomib Resistance Identifies Secondary Therapies in a Mouse Myeloma Model 2013 ·Molecular Cancer Therapeutics ·Holly A.F. Stessman, Linda B. Baughn, Aaron L. Sarver, Tian Xia, Raamesh Deshpande, (unknown), Susan A. Walsh, John J. Sunderland, Nathan G. Dolloff, Michael A. Linden, Fenghuang Zhan, Siegfried Janz, Chad L. Myers, Brian G. Van Ness	62
13	Triptolide Induces the Expression of miR-142-3p: A Negative Regulator of Heat Shock Protein 70 and Pancreatic Cancer Cell Proliferation 2013 ·Molecular Cancer Therapeutics ·Tiffany N. MacKenzie, Nameeta Mujumdar, Sulagna Banerjee, Veena Sangwan, Aaron L. Sarver, Selwyn M. Vickers, Subbaya Subramanian, Ashok K. Saluja	118
14	Canonical Wnt/β-catenin Signaling Drives Human Schwann Cell Transformation, Progression, and Tumor Maintenance 2013 ·Cancer Discovery ·Adrienne L. Watson, Eric P. Rahrmann, Branden S. Moriarity, Kwangmin Choi, Caitlin B. Conboy, (unknown), (unknown), (unknown), (unknown), Vincent W. Keng, Anthony E. Rizzardi, Colleen L. Forster, Margaret H. Collins, Aaron L. Sarver, Margaret R. Wallace, Stephen C. Schmechel, Nancy Ratner, David A. Largaespada	76
15	BRCA1 is a negative modulator of the PRC2 complex 2013 ·The EMBO Journal ·Lan Wang, (unknown), Shuai Chen, Liya Ding, Jian Zhong, Jonathan C. Zhao, Liguo Wang, Aaron L. Sarver, Antonius Koller, Jizu Zhi, Yupo Ma, Jindan Yu, Junjie Chen, Haojie Huang	92
16	MicroRNAs at the human 14q32 locus have prognostic significance in osteosarcoma 2013 ·Orphanet Journal of Rare Diseases ·Aaron L. Sarver, Venugopal Thayanithy, Milcah C. Scott, (unknown), Pancras C.W. Hogendoorn, Jaime F. Modiano, Subbaya Subramanian	82
17	Oxygen Is a Master Regulator of the Immunogenicity of Primary Human Glioma Cells 2011 ·Cancer Research ·Michael R. Olin, Brian M. Andersen, Adam J. Litterman, Patrick T. Grogan, Aaron L. Sarver, (unknown), Xueqing Liang, Wei Chen, Ian F. Parney, Matthew A. Hunt, Bruce R. Blazar, John R. Ohlfest	17
18	The molecular and cellular basis of variable craniofacial phenotypes and their genetic rescue in Twisted gastrulation mutant mice 2011 ·Developmental Biology ·Charles J. Billington, (unknown), Cynthia L. Forsman, Brian Schmidt, Anindya Bagchi, David E. Symer, Gunnar Schotta, Rajaram Gopalakrishnan, Aaron L. Sarver, Anna Petryk	12
19	miRNA Expression in Colon Polyps Provides Evidence for a Multihit Model of Colon Cancer 2011 ·PLoS ONE ·Ann L. Oberg, Amy J. French, Aaron L. Sarver, Subbaya Subramanian, Bruce W. Morlan, Shaun M. Riska, Pedro M. Borralho, Julie M. Cunningham, Lisa A. Boardman, Liang Wang, Thomas C. Smyrk, Yan W. Asmann, Clifford J. Steer, Stephen N. Thibodeau	117
20	MicroRNA miR-183 Functions as an Oncogene by Targeting the Transcription Factor EGR1 and Promoting Tumor Cell Migration 2010 ·Cancer Research ·Aaron L. Sarver, Lihua Li, Subbaya Subramanian	245

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact